Healthcare Value Capital as of June 30, 2012
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 44 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| St. Jude Medical | 9.3 | $14M | 339k | 39.91 | |
| Forest Laboratories | 9.1 | $13M | 376k | 34.99 | |
| AstraZeneca (AZN) | 7.7 | $11M | 248k | 44.75 | |
| Sanofi-Aventis SA (SNY) | 7.4 | $11M | 285k | 37.78 | |
| Medicis Pharmaceutical Corporation | 5.7 | $8.2M | 241k | 34.15 | |
| Pfizer (PFE) | 5.2 | $7.6M | 329k | 23.00 | |
| Merck & Co (MRK) | 4.2 | $6.1M | 147k | 41.75 | |
| Omnicare | 3.7 | $5.3M | 170k | 31.23 | |
| AmerisourceBergen (COR) | 3.2 | $4.7M | 120k | 39.35 | |
| Pacira Pharmaceuticals (PCRX) | 3.1 | $4.4M | 277k | 16.04 | |
| NuVasive | 2.6 | $3.8M | 150k | 25.36 | |
| Walgreen Company | 2.4 | $3.5M | 120k | 29.59 | |
| SPDR S&P MidCap 400 ETF (MDY) | 2.4 | $3.4M | 20k | 171.30 | |
| Johnson & Johnson (JNJ) | 2.3 | $3.4M | 50k | 67.56 | |
| Allscripts Healthcare Solutions (MDRX) | 2.3 | $3.3M | 305k | 10.93 | |
| Abbott Laboratories (ABT) | 2.2 | $3.2M | 50k | 64.48 | |
| Qlt | 2.1 | $3.1M | 404k | 7.62 | |
| Obagi Medical Products | 2.1 | $3.0M | 198k | 15.27 | |
| Covidien | 1.9 | $2.7M | 50k | 53.50 | |
| Eli Lilly & Co. (LLY) | 1.8 | $2.6M | 60k | 42.92 | |
| Impax Laboratories | 1.8 | $2.5M | 125k | 20.27 | |
| Charles River Laboratories (CRL) | 1.6 | $2.4M | 73k | 32.76 | |
| Laboratory Corp. of America Holdings (LH) | 1.6 | $2.3M | 25k | 92.60 | |
| Boston Scientific Corporation (BSX) | 1.6 | $2.3M | 408k | 5.67 | |
| Elan Corporation | 1.5 | $2.2M | 150k | 14.59 | |
| CryoLife (AORT) | 1.4 | $2.0M | 375k | 5.23 | |
| Sigma-Aldrich Corporation | 1.3 | $1.8M | 25k | 73.92 | |
| Gilead Sciences (GILD) | 1.2 | $1.8M | 35k | 51.29 | |
| Hca Holdings (HCA) | 1.1 | $1.7M | 55k | 30.43 | |
| Onyx Pharmaceuticals | 1.1 | $1.7M | 25k | 66.44 | |
| Celgene Corporation | 1.1 | $1.6M | 25k | 64.16 | |
| Clovis Oncology | 0.8 | $1.1M | 52k | 21.68 | |
| ViroPharma Incorporated | 0.5 | $711k | 30k | 23.70 | |
| Human Genome Sciences | 0.5 | $657k | 50k | 13.14 | |
| Sunesis Pharmaceuticals | 0.4 | $580k | 202k | 2.87 | |
| Medicines Company | 0.4 | $557k | 24k | 22.92 | |
| MAKO Surgical | 0.3 | $512k | 20k | 25.60 | |
| Celsion Corporation | 0.3 | $391k | 127k | 3.07 | |
| PROLOR Biotech | 0.2 | $285k | 57k | 5.00 | |
| Synta Pharmaceuticals | 0.2 | $274k | 50k | 5.48 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $220k | 50k | 4.40 | |
| Halozyme Therapeutics (HALO) | 0.1 | $222k | 25k | 8.88 | |
| Myrexis (MYRX) | 0.1 | $156k | 60k | 2.61 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $138k | 10k | 13.80 |
